Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
09 2021
Historique:
received: 20 10 2019
accepted: 30 04 2020
revised: 28 04 2020
pubmed: 30 5 2020
medline: 1 2 2022
entrez: 30 5 2020
Statut: ppublish

Résumé

Emerging evidence suggests that obesity impacts brain physiology at multiple levels. Here we aimed to clarify the relationship between obesity and brain structure using structural MRI (n = 6420) and genetic data (n = 3907) from the ENIGMA Major Depressive Disorder (MDD) working group. Obesity (BMI > 30) was significantly associated with cortical and subcortical abnormalities in both mass-univariate and multivariate pattern recognition analyses independent of MDD diagnosis. The most pronounced effects were found for associations between obesity and lower temporo-frontal cortical thickness (maximum Cohen´s d (left fusiform gyrus) = -0.33). The observed regional distribution and effect size of cortical thickness reductions in obesity revealed considerable similarities with corresponding patterns of lower cortical thickness in previously published studies of neuropsychiatric disorders. A higher polygenic risk score for obesity significantly correlated with lower occipital surface area. In addition, a significant age-by-obesity interaction on cortical thickness emerged driven by lower thickness in older participants. Our findings suggest a neurobiological interaction between obesity and brain structure under physiological and pathological brain conditions.

Identifiants

pubmed: 32467648
doi: 10.1038/s41380-020-0774-9
pii: 10.1038/s41380-020-0774-9
pmc: PMC8589644
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4839-4852

Subventions

Organisme : NIMH NIH HHS
ID : RC2 MH089951
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH081802
Pays : United States
Organisme : NCRR NIH HHS
ID : P41 RR008079
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089995
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH090421
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH117601
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042157
Pays : United States
Organisme : Wellcome Trust
ID : 104036/Z/14/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020. The Author(s).

Références

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–98.
pubmed: 30814686
World Health Organization. Obesity and overweight. 2014. http://www.who.int/mediacentre/factsheets/fs311/en/ .
Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, et al. Brain structure and obesity. Hum Brain Mapp. 2010;31:353–64.
pubmed: 19662657
Bobb JF, Schwartz BS, Davatzikos C, Caffo B. Cross-sectional and longitudinal association of body mass index and brain volume. Hum Brain Mapp. 2014;35:75–88.
pubmed: 23008165
Repple J, Opel N, Meinert S, Redlich R, Hahn T, Winter NR, et al. Elevated body-mass index is associated with reduced white matter integrity in two large independent cohorts. Psychoneuroendocrinology. 2018;91:179–85.
pubmed: 29571075
Opel N, Redlich R, Grotegerd D, Dohm K, Haupenthal C, Heindel W, et al. Enhanced neural responsiveness to reward associated with obesity in the absence of food-related stimuli. Hum Brain Mapp. 2015;36:2330–7.
pubmed: 25704752 pmcid: 6869351
Stice E, Yokum S, Burger KS, Epstein LH, Small DM. Youth at risk for obesity show greater activation of striatal and somatosensory regions to food. J Neurosci. 2011;31:4360–6.
pubmed: 21430137 pmcid: 3260083
Burger KS, Berner LA. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav. 2014. https://doi.org/10.1016/j.physbeh.2014.04.025 .
doi: 10.1016/j.physbeh.2014.04.025 pubmed: 25447334 pmcid: 4258533
Opel N, Redlich R, Grotegerd D, Dohm K, Heindel W, Kugel H, et al. Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology. 2015;51:219–26.
pubmed: 25462895
Janowitz D, Wittfeld K, Terock J, Freyberger HJ, Hegenscheid K, Völzke H, et al. Association between waist circumference and gray matter volume in 2344 individuals from two adult community-based samples. Neuroimage. 2015;122:149–57.
pubmed: 26256530
Hamer M, Batty GD. Association of body mass index and waist-to-hip ratio with brain structure. Neurology. 2019. https://doi.org/10.1212/WNL.0000000000006879.
doi: 10.1212/WNL.0000000000006879. pubmed: 31068484 pmcid: 6556095
García-García I, Michaud A, Dadar M, Zeighami Y, Neseliler S, Collins DL, et al. Neuroanatomical differences in obesity: meta-analytic findings and their validation in an independent dataset. Int J Obes. 2018. https://doi.org/10.1038/s41366-018-0164-4 .
doi: 10.1038/s41366-018-0164-4
Perlaki G, Molnar D, Smeets PAM, Ahrens W, Wolters M, Eiben G, et al. Volumetric gray matter measures of amygdala and accumbens in childhood overweight/obesity. PLoS One. 2018;13:e0205331.
pubmed: 30335775 pmcid: 6193643
Medic N, Ziauddeen H, Ersche KD, Farooqi IS, Bullmore ET, Nathan PJ, et al. Increased body mass index is associated with specific regional alterations in brain structure. Int J Obes. 2016;40:1177–82.
Reddan MC, Lindquist MA, Wager TD. Effect size estimation in neuroimaging. JAMA Psychiatry. 2017;74:207.
pubmed: 28099973
Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824.
pubmed: 16818872 pmcid: 1913935
Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24:18–33.
pubmed: 29453413
Luppino F, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx B, et al. Overweight, obesity, and depression. Arch Gen Psychiatry. 2010;67:220–9.
pubmed: 20194822
Schmaal L, Hibar DP, Sämann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017;22:900–9.
pubmed: 27137745
Marqués-Iturria I, Pueyo R, Garolera M, Segura B, Junqué C, García-García I, et al. Frontal cortical thinning and subcortical volume reductions in early adulthood obesity. Psychiatry Res Neuroimaging. 2013;214:109–15.
Sharkey RJ, Karama S, Dagher A. Overweight is not associated with cortical thickness alterations in children. Front Neurosci. 2015;9:24.
pubmed: 25698918 pmcid: 4316697
Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N. Engl J Med. 1990;322:1483–7.
pubmed: 2336075
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
pubmed: 25673413 pmcid: 4382211
Opel N, Redlich R, Kaehler C, Grotegerd D, Dohm K, Heindel W, et al. Prefrontal gray matter volume mediates genetic risks for obesity. Mol Psychiatry. 2017;22:703–10.
pubmed: 28348383
Wolf EJ, Miller DR, Logue MW, Sumner J, Stoop TB, Leritz EC, et al. Contributions of polygenic risk for obesity to PTSD-related metabolic syndrome and cortical thickness. Brain Behav Immun. 2017;65:328–36.
pubmed: 28579519 pmcid: 5537007
Schmaal L, Veltman DJ, van Erp TGM, Sämann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016;21:806–12.
pubmed: 26122586
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.
pubmed: 11832223
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80.
Storsve AB, Fjell AM, Tamnes CK, Westlye LT, Overbye K, Aasland HW, et al. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J Neurosci. 2014;34:8488–98.
pubmed: 24948804 pmcid: 6608217
Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage. 2010;53:1135–46.
pubmed: 20006715
Euesden J, Lewis CM, O’Reilly PF. PRSice: polygenic risk score software. Bioinformatics. 2015;31:1466–8.
pubmed: 25550326
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
pubmed: 25722852 pmcid: 4342193
Rosenthal R, Rosnow RL. Essentials of Behavioral Research: Methods Data Anal. 2008.
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry. 2018;23:932–42.
pubmed: 28461699
van Rooij D, Anagnostou E, Arango C, Auzias G, Behrmann M, Busatto GF, et al. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD Working Group. Am J Psychiatry. 2018;175:359–69.
pubmed: 29145754
Ronan L, Alexander-Bloch AF, Wagstyl K, Farooqi S, Brayne C, Tyler LK, et al. Obesity associated with increased brain age from midlife. Neurobiol Aging. 2016;47:63–70.
pubmed: 27562529 pmcid: 5082766
Hogstrom LJ, Westlye LT, Walhovd KB, Fjell AM. The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. Cereb Cortex. 2013;23:2521–30.
pubmed: 22892423
Seldon HL. Does brain white matter growth expand the cortex like a balloon? Hypothesis and consequences. Laterality Asymmetries Body Brain Cogn. 2005;10:81–95.
Bernardes G, IJzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, et al. Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin. Metab Brain Dis. 2018;33:1211–22.
pubmed: 29654499 pmcid: 6060745
Widya RL, De Roos A, Trompet S, De Craen AJM, Westendorp RGJ, Smit JWA, et al. Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular disease. Am J Clin Nutr. 2011;93:1190–5.
pubmed: 21450935
Kharabian Masouleh S, Arélin K, Horstmann A, Lampe L, Kipping JA, Luck T, et al. Higher body mass index in older adults is associated with lower gray matter volume: implications for memory performance. Neurobiol Aging. 2016;40:1–10.
pubmed: 26973099
Boedhoe PSW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the ENIGMA Obsessive-Compulsive Disorder Working Group. Am J Psychiatry. 2018;175:453–62.
pubmed: 29377733
Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry. 2019;176:119–28.
pubmed: 30336705
Nunes A, Schnack HG, Ching CRK, Agartz I, Akudjedu TN, Alda M et al. Using structural MRI to identify bipolar disorders—13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group. Mol Psychiatry. 2018. https://doi.org/10.1038/s41380-018-0228-9 . [Epub ahead of print].
Cole JH, Poudel RPK, Tsagkrasoulis D, Caan MWA, Steves C, Spector TD, et al. Predicting brain age with deep learning from raw imaging data results in a reliable and heritable biomarker. Neuroimage. 2017;163:115–24.
pubmed: 28765056
Koutsouleris N, Davatzikos C, Borgwardt S, Gaser C, Bottlender R, Frodl T, et al. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull. 2014;40:1140–53.
pubmed: 24126515
Cole JH, Boyle CP, Simmons A, Cohen-Woods S, Rivera M, McGuffin P, et al. Body mass index, but not FTO genotype or major depressive disorder, influences brain structure. Neuroscience. 2013;252:109–17.
pubmed: 23933215
Rangel A. Regulation of dietary choice by the decision-making circuitry. Nat Neurosci. 2013;16:1717–24.
pubmed: 24270272 pmcid: 4053793
Meyer MD, Risbrough VB, Liang J, Boutelle KN. Pavlovian conditioning to hedonic food cues in overweight and lean individuals. Appetite. 2015;87:56–61.
pubmed: 25526826
Veit R, Kullmann S, Heni M, Machann J, Häring H-U, Fritsche A, et al. Reduced cortical thickness associated with visceral fat and BMI. NeuroImage Clin. 2014;6:307–11.
pubmed: 25379443 pmcid: 4215386
Beyer F, García‐García I, Heinrich M, Schroeter ML, Sacher J, Luck T, et al. Neuroanatomical correlates of food addiction symptoms and body mass index in the general population. Hum Brain Mapp. 2019;40:2747–58.
pubmed: 30816616 pmcid: 6865576
Willer CJ, Speliotes EK, Loos RJF, Li S, Lindgren CM, Heid IM, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25–34.
pubmed: 19079261
Ho JE, Larson MG, Ghorbani A, Cheng S, Chen M-H, Keyes M, et al. Metabolomic profiles of body mass index in the framingham heart study reveal distinct cardiometabolic phenotypes. PLoS One. 2016;11:e0148361.
pubmed: 26863521 pmcid: 4749349
Favennec M, Hennart B, Caiazzo R, Leloire A, Yengo L, Verbanck M, et al. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity. 2015;23:2066–74.
pubmed: 26347385
Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465–77.
pubmed: 22678511 pmcid: 3681811
Kuzawa CW, Blair C. A hypothesis linking the energy demand of the brain to obesity risk. Proc Natl Acad Sci. 2019;116:13266–75.
pubmed: 31209026 pmcid: 6612912
Goyal MS, Blazey TM, Su Y, Couture LE, Durbin TJ, Bateman RJ, et al. Persistent metabolic youth in the aging female brain. Proc Natl Acad Sci USA. 2019;116:3251–5.
pubmed: 30718410 pmcid: 6386682

Auteurs

Nils Opel (N)

Department of Psychiatry, University of Münster, Münster, Germany. n_opel01@uni-muenster.de.
Interdisciplinary Centre for Clinical Research (IZKF), University of Münster, Münster, Germany. n_opel01@uni-muenster.de.

Anbupalam Thalamuthu (A)

Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Neuroscience Research Australia, Randwick, NSW, Australia.

Yuri Milaneschi (Y)

Department of Psychiatry, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.

Dominik Grotegerd (D)

Department of Psychiatry, University of Münster, Münster, Germany.

Claas Flint (C)

Department of Psychiatry, University of Münster, Münster, Germany.
Faculty of Mathematics and Computer Science, University of Münster, Münster, Germany.

Ramona Leenings (R)

Department of Psychiatry, University of Münster, Münster, Germany.

Janik Goltermann (J)

Department of Psychiatry, University of Münster, Münster, Germany.

Maike Richter (M)

Department of Psychiatry, University of Münster, Münster, Germany.

Tim Hahn (T)

Department of Psychiatry, University of Münster, Münster, Germany.

Georg Woditsch (G)

IT Department, University of Muenster, Münster, Germany.

Klaus Berger (K)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Marco Hermesdorf (M)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Andrew McIntosh (A)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Heather C Whalley (HC)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Mathew A Harris (MA)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Frank P MacMaster (FP)

Psychiatry and Paediatrics, University of Calgary, Calgary, AB, Canada.
Addictions and Mental Health Strategic Clinical Network Calgary, Calgary, AB, Canada.

Henrik Walter (H)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Ilya M Veer (IM)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Thomas Frodl (T)

Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Angela Carballedo (A)

Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.

Axel Krug (A)

Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.

Igor Nenadic (I)

Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.

Andre Aleman (A)

Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Nynke A Groenewold (NA)

Department of Biomedical Sciences of Cells and Systems, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Dan J Stein (DJ)

SA MRC Unit on Risk & Resilience, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Jair C Soares (JC)

UT Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.

Giovana B Zunta-Soares (GB)

UT Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.

Benson Mwangi (B)

Department of Psychiatry, University of Texas Health Science Center at Houston, Houston, TX, USA.

Mon-Ju Wu (MJ)

Department of Psychiatry, University of Texas Health Science Center at Houston, Houston, TX, USA.

Martin Walter (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.

Meng Li (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.

Ben J Harrison (BJ)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Parkville, VIC, Australia.

Christopher G Davey (CG)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Kathryn R Cullen (KR)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Minnesota, Minneapolis, MN, USA.

Bonnie Klimes-Dougan (B)

Department of Psychology, University of Minnesota, Minneapolis, MN, USA.

Bryon A Mueller (BA)

Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Minnesota, Minneapolis, MN, USA.

Philipp G Sämann (PG)

Max Planck Institute of Psychiatry, Munich, Germany.

Brenda Penninx (B)

Department of Psychiatry, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.

Laura Nawijn (L)

Department of Psychiatry, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.

Dick J Veltman (DJ)

Department of Psychiatry, Amsterdam UMC/Vrije Universiteit, Amsterdam, Netherlands.

Lyubomir Aftanas (L)

FSSBI "Scientific Research Institute of Physiology & Basic Medicine", Laboratory of Affective, Cognitive & Translational Neuroscience, Novosibirsk, Russia.

Ivan V Brak (IV)

FSSBI "Scientific Research Institute of Physiology & Basic Medicine", Laboratory of Affective, Cognitive & Translational Neuroscience, Novosibirsk, Russia.

Elena A Filimonova (EA)

FSSBI "Scientific Research Institute of Physiology & Basic Medicine", Laboratory of Affective, Cognitive & Translational Neuroscience, Novosibirsk, Russia.

Evgeniy A Osipov (EA)

Novosibirsk State University, Laboratory of Experimental & Translational Neuroscience, Novosibirsk, Russia.

Liesbeth Reneman (L)

Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Anouk Schrantee (A)

Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Greifswald/Rostock, site Greifswald, Greifswald, Germany.

Sandra Van der Auwera (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Greifswald/Rostock, site Greifswald, Greifswald, Germany.

Katharina Wittfeld (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Greifswald/Rostock, site Greifswald, Greifswald, Germany.

Norbert Hosten (N)

Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Henry Völzke (H)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Greifswald, Greifswald, Germany.

Kang Sim (K)

West Region, Institute of Mental Health, Singapore, Singapore.
Yoo Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Ian H Gotlib (IH)

Department of Psychology, Stanford University, Stanford, CA, USA.

Matthew D Sacchet (MD)

Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.

Jim Lagopoulos (J)

Sunshine Coast Mind and Neuroscience Thompson Institute, University of the Sunshine Coast, Sippy Downs, QLD, Australia.

Sean N Hatton (SN)

Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.

Ian Hickie (I)

Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.

Elena Pozzi (E)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.

Paul M Thompson (PM)

Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Neda Jahanshad (N)

Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Udo Dannlowski (U)

Department of Psychiatry, University of Münster, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH